Meet Proteona at the AVCO Annual Conference 2019 in Vienna, Austria
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Dr Andreas Schmidt, the CEO of Proteona Pte. Ltd., will be presenting at the AVCO Annual Conference 2019, taking place on the 3rd of October in Vienna, Austria.
Dr Schmidt will speak in the panel “Investing in Healthcare Opportunities in Europe” at 17:10pm. The annual conference is Austria’s leading event for investors and entrepreneurs.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a new biomedical company based in Singapore, Germany, and the US that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.